Document:

Term Loan Second Amendment

 Exhibit 10.2 
 SECOND AMENDMENT TO SECOND AMENDED 
 AND RESTATED LETTER AGREEMENT 
 October 23, 2006 
 II-VI
Japan Incorporated 
 C/o II-VI Incorporated 
 375 Saxonburg Boulevard 
 Saxonburg, PA 16056 
 Re: 300,000,000 Japanese Yen Term Loan 
 Gentlemen: 
 Reference is
made to the Second Amended and Restated Letter Agreement dated September 25, 2002, as amended by Amendment to Second Amended and Restated Letter Agreement dated December 10, 2004, (as so amended, the “Letter Agreement”) between
PNC Bank, National Association (the “Bank”) and II-VI Japan Incorporated (the “Borrower”). 
 The Letter Agreement is
hereby amended as follows: 
 1. The definition of “Credit Agreement” set forth is Schedule 1 to the Letter Agreement is amended and
restated as follows: 
 Credit Agreement shall mean the Credit Agreement dated as of October 23, 2006, among II-VI, the Guarantors
party thereto, the Banks party thereto, and PNC Bank, National Association, as Agent, as it may be hereafter amended, restated, modified or supplemented from time to time. In the event that the Credit Agreement is terminated or the Bank is no longer
a lender under the Credit Agreement, the term Credit Agreement shall mean the Credit Agreement as it exists immediately prior to (i) such termination or (ii) the date on which the Bank is no longer a “Bank” under the
Credit Agreement. 
 2. Except as expressly provided herein, the Letter Agreement shall remain in full force and effect. 

 Witness the due execution hereof: 
  

			
	PNC Bank, National Association
		
	By:	 	 /s/ Troy Brown

	Title:	 	Vice President
	
	II-VI Japan Incorporated
		
	By:	 	 /s/ Yasuhiro Sakakibara

	Title:	 	President

 The undersigned II-VI Incorporated, the Guarantor with respect to and as defined in the above
referenced Letter Agreement, hereby affirms its obligation under such Guarantee. 
  

			
	II-VI Incorporated
		
	By:	 	 /s/ Craig A. Creaturo

	Title:	 	Chief Financial Officer and TreasurerSecond Allonge to Rate Protection Term Note

 Exhibit 10.3 
 SECOND ALLONGE TO RATE PROTECTION TERM NOTE 
 Reference is made to the Rate Protection Term Note dated September 25,
2002 made by II-VI Japan Incorporated in favor of PNC Bank, National Association, as amended by Allonge to Rate Protection Tern Note dated September 25, 2006 (as so amended, the “Note”). 
 1. Section 2(a) of the Note is hereby amended to delete the phrase “December 25, 2007” and to insert in lieu thereof the phase “ September 30,
2011”. 
 2. Except as set for the above, the Note shall remain unamended and in full force and effect. 
 Witness the due execution hereof this 23rd day of October, 2006. 
  

									
		 		 	II-VI JAPAN INCORPORATED	 	
					
	WITNESS / ATTEST:	 		 		 		 	
					
	 /s/ Miwa Izu
	 		 	By:	 	 /s/ Yasuhiro Sakakibara
	 	(SEAL)
	Print Name: Miwa Izu	 		 	Print Name:	 	Yasuhiro Sakakibara	 	
	Title: Accountant	 		 	Title:	 	President	 	
				
		 		 	PNC BANK, NATIONAL ASSOCIATION	 	
					
		 		 	By:	 	 /s/ Troy Brown
	 	
		 		 	Print Name:	 	Troy Brown	 	
		 		 	Title:	 	Vice PresidentWarrant Clarification Agreement

 Exhibit 4.1 
 WARRANT CLARIFICATION AGREEMENT 
 This Warrant Clarification Agreement (this
“Agreement”), dated October 25, 2006, is to the Warrant Agreement, dated as of April 21, 2005 (the “Warrant Agreement”), by and between KBL Healthcare Acquisition Corp. II, a Delaware corporation (“Company”),
and Continental Stock Transfer & Trust Company, a New York corporation (“Warrant Agent”). 
 WHEREAS,
Section 3.3.2 of the Warrant Agreement provides that Company shall not be obligated to deliver any securities pursuant to the exercise of a warrant unless a registration statement under the Securities Act of 1933, as amended (“Securities
Act”), with respect to the common stock is effective. 
 WHEREAS, in furtherance of the foregoing, the Company’s final
prospectus, dated April 21, 2005, indicated (i) that no warrant would be exercisable unless at the time of exercise a prospectus relating to the common stock issuable upon exercise of the warrant is current and the common stock has been
registered under the Securities Act or qualified or deemed to be exempt under the securities laws of the state of residence of the holder of the warrant and (ii) that the warrant may be deprived of any value and the market for the warrant may
be limited if the prospectus relating to the common stock issuable upon the exercise of the warrant is not current or if the common stock is not qualified or exempt from qualification in the jurisdictions in which the holder of the warrant resides.

 WHEREAS, as a result of certain questions that have arisen regarding the accounting treatment applicable to the warrants, the
parties hereto deem it necessary and desirable to amend the Warrant Agreement to clarify that the registered holders do not have the right to receive a net cash settlement in the event the Company does not maintain a current prospectus relating to
the common stock issuable upon exercise of the warrants at the time such warrants are exercisable. 
 NOW, THEREFORE, in consideration
of the mutual agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the parties hereto agree to amend the Warrant Agreement as
set forth herein. 
 1. Warrant Agreement. The Warrant Agreement is hereby clarified by adding the following sentence as the
penultimate sentence of Section 3.3.2: 
 “Furthermore, if the Company is unable to deliver any securities pursuant
to the exercise of a Warrant as a result of the foregoing situations, the Company will have no obligation to pay such registered holder any cash or other consideration or otherwise “net cash settle” the Warrant.” 
 2. Miscellaneous. 
 (a) Governing
Law. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the
application of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State
of New York or the 

 
United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The
Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any such process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or
certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 9.2 of the Warrant Agreement. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any
action, proceeding or claim. 
 (b) Binding Effect. This Agreement shall be binding upon and inure to the benefit of the parties
hereto and to their respective heirs, legal representatives, successors and assigns. 
 (c) Entire Agreement. This Agreement sets
forth the entire agreement and understanding between the parties as to the subject matter thereof and merges and supersedes all prior discussions, agreements and understandings of any and every nature among them. Except as set forth in this
Agreement, provisions of the Warrant Agreement which are not inconsistent with this Agreement shall remain in full force and effect. This Agreement may be executed in counterparts. 
 (d) Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not
affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as part of this
Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable. 

 IN WITNESS WHEREOF, the parties hereto have executed this Warrant Clarification Agreement as of the date
first written above. 
  

			
	 KBL HEALTHCARE ACQUISITION CORP. II

		
	 By:
	 	 /s/ Michael Kaswan

		 	 Michael Kaswan, Chief Operating Officer

	
	 CONTINENTAL STOCK TRANSFER & TRUST COMPANY

		
	 By:
	 	 /s/ Frank DiPaolo

		 	 Frank DiPaolo, Chief Financial OfficerAmendment to Unit Purchase Options

 Exhibit 4.2 
 AMENDMENT TO 
 UNIT PURCHASE OPTIONS 
 This AMENDMENT TO UNIT PURCHASE OPTIONS (this “Amendment”), dated October 25, 2006, is made by and between KBL Healthcare Acquisition
Corp. II (the “Company”) and the holders designated on the signature page hereof (“Holders”), to those certain Unit Purchase Options referred to below. 
 WHEREAS, the Company issued those certain Unit Purchase Options, dated April 21, 2005 (the “Unit Purchase Options”), in connection with
the Company’s initial public offering and the Holders are the owners of the Unit Purchase Options; and 
 WHEREAS, the parties hereto
have agreed that the Unit Purchase Options be amended as set forth herein to clarify the understanding between the parties with respect to the terms of the Unit Purchase Options effective as of the date of their issuance. 
 NOW, THEREFORE, in consideration of the premises and of the agreements contained herein, the parties hereto hereby agree as follows: 
 1. The Unit Purchase Options are hereby amended by adding the following new Section 2.4 to such Unit Purchase Options: 
 “2.4 No Obligation to Net Cash Settle. Notwithstanding anything to the contrary contained in this Purchase Option, if the Company is unable
to deliver any securities pursuant to the exercise of this Purchase Option as a result of its inability to satisfy its registration requirements set forth in Section 5 hereof, the Company will have no obligation to pay such registered holder
any cash or otherwise “net cash settle” the Purchase Option or the Warrants underlying the Purchase Option.” 
 2.
Section 5.3 of the Unit Purchase Options is hereby deleted in its entirety. 
 3. Upon the due execution and delivery of this Amendment
by the parties hereto, on and after the date hereof each reference in the Unit Purchase Options to this “Purchase Option”, “hereunder”, “hereof”, “herein” or words of like import referring to the Unit Purchase
Options shall mean and be a reference to the Unit Purchase Options, as amended hereby. Except as specifically amended above, the Unit Purchase Options shall remain in full force and effect and is hereby ratified and confirmed. 
 4. This Amendment may be executed in one or more counterparts, and by the different parties hereto in separate counterparts, each of which shall be
deemed to be an original, but all of which taken together shall constitute one and the same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered to each of the other parties
hereto. 

 IN WITNESS WHEREOF, the parties have executed this AMENDMENT TO UNIT PURCHASE OPTIONS as of the date
first set forth above. 
  

					
		 	 KBL HEALTHCARE ACQUISITION CORP. II

		
	 By:
	 	 /s/ Michael Kaswan

		 	 Name:
	 	 Michael Kaswan

		 	 Title:
	 	 Chief Operating Officer

		
		 	 HOLDERS:

		
		 	 EARLYBIRDCAPITAL, INC.

		
	 By:
	 	 /s/ Steve Levine

		 	 Name:
	 	 Steve Levine

		 	 Title:
	 	 Chief Executive Officer

		
		 	 /s/ David M. Nussbaum

		 	 David M. Nussbaum

		
		 	 /s/ Steve Levine

		 	 Steve Levine

		
		 	 /s/ Pat Steo

		 	 Pat Steo

		
		 	 /s/ Eileen Moore

		 	 Eileen Moore

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}]]